Two-Drug attack on colon cancer before surgery
NCT ID NCT07224022
Summary
This study is testing whether two immunotherapy drugs, cemiplimab and fianlimab, can safely shrink colon tumors before surgery. The goal is to see if giving these drugs first makes the surgery more effective and helps prevent the cancer from coming back. About 24 adults with stage II or III colon cancer that hasn't spread will receive two IV doses of the drugs, then have surgery, and be followed for up to three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.